Qualigen Therapeutics, Inc. (QLGN)

NASDAQ: QLGN · IEX Real-Time Price · USD

0.272

-0.021 (-7.10%)

At close: Jul 22, 2024, 9:12 AM

0.265

-0.007 (-2.68%)

Pre-market: Jul 22, 2024, 9:21 AM EDT

Qualigen Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Mar 31, 2020	Dec 31, 2019	2018 - 2013
Market Capitalization	3	3	5	31	12	2	Upgrade
Market Cap Growth	-46.80%	-47.50%	-82.58%	155.25%	610.94%	-50.10%	Upgrade
Enterprise Value	4	4	2	15	14	0	Upgrade
PE Ratio	-	-0.21	-0.29	-1.74	-6.83	-0.17	Upgrade
PS Ratio	2.05	-	-	5.51	2.20	-	Upgrade
PB Ratio	-0.59	-1.35	0.75	1.88	-6.33	1.56	Upgrade
P/FCF Ratio	-0.25	-0.28	-0.41	-2.10	242.38	-0.12	Upgrade
P/OCF Ratio	-0.25	-0.28	-0.41	-2.11	212.90	-0.12	Upgrade
EV/Sales Ratio	2.62	-	-	2.71	2.57	-	Upgrade
EV/EBITDA Ratio	-0.28	-0.32	-0.12	-0.87	-11.12	-0.01	Upgrade
EV/EBIT Ratio	-0.29	-0.31	-0.12	-0.85	-9.51	-0.01	Upgrade
EV/FCF Ratio	-0.36	-0.36	-0.18	-1.03	283.41	-0.01	Upgrade
Debt / Equity Ratio	-0.29	-0.62	0.01	0.10	-1.15	0.09	Upgrade
Debt / EBITDA Ratio	-0.10	-0.11	0.00	-0.10	-1.73	-0.01	Upgrade
Debt / FCF Ratio	-0.12	-0.13	0.00	-0.11	44.07	-0.01	Upgrade
Quick Ratio	0.02	0.10	0.37	3.96	0.16	1.00	Upgrade
Current Ratio	0.22	0.28	1.26	4.49	0.30	1.30	Upgrade
Asset Turnover	0.32	0	0	0.27	1.54	0	Upgrade
Interest Coverage	-9.42	-7.80	-540.73	-	-5.30	-	Upgrade
Return on Equity (ROE)	891.80%	-1698.70%	-157.40%	-128.10%	-521.60%	-498.70%	Upgrade
Return on Assets (ROA)	-227.60%	-151.60%	-85.60%	-84.40%	-49.50%	-206.00%	Upgrade
Return on Capital (ROIC)	401.20%	1405.48%	-202.32%	-124.24%	-516.05%	-903.34%	Upgrade
Earnings Yield	-349.96%	-470.85%	-343.41%	-57.44%	-14.65%	-590.22%	Upgrade
FCF Yield	-247.71%	-361.61%	-244.06%	-47.71%	0.41%	-845.65%	Upgrade
Buyback Yield / Dilution	-19.86%	-32.09%	-30.91%	-423.63%	-1363.48%	-80.40%	Upgrade
Total Shareholder Return	-19.86%	-32.09%	-30.91%	-423.63%	-1363.48%	-80.40%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).